Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 4
1992 3
1993 3
1994 5
1996 5
1997 6
1998 2
1999 6
2000 4
2001 4
2002 5
2003 4
2004 5
2005 9
2006 10
2007 7
2008 7
2009 7
2010 9
2011 9
2012 15
2013 12
2014 14
2015 11
2016 12
2017 18
2018 19
2019 18
2020 20
2021 20
2022 21
2023 17
2024 16
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

301 results

Results by year

Filters applied: . Clear all
Page 1
Ruxolitinib for refractory lung granulomatosis in two pediatric patients.
Michelet M, Fournier B, Terrier B, Valeyre D, Bernaudin JF, Lozach C, Brochard K, Khen-Dunlop N, Delacourt C, Berteloot L, Vigier A, Berrebi D, Bader-Meunier B, Drummond D. Michelet M, et al. Among authors: bader meunier b. Rheumatology (Oxford). 2025 Jun 12:keaf333. doi: 10.1093/rheumatology/keaf333. Online ahead of print. Rheumatology (Oxford). 2025. PMID: 40504025 No abstract available.
Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies.
Robert M, Nguyen Y, Allenbach Y, Sacre K, Terrier B, Borie R, Uzunhan Y, Amoura Z, Comparon C, Dieudé P, Le Guern V, Morelot-Panzini C, Humbert M, Sitbon O, Goujard C, Bader-Meunier B, Fautrel B, Chretien P, Roland-Nicaise P, Goulvestre C, Charuel JL, Benveniste O, Mouthon L, De Lastours V, Dusser P, Zaidan M, Aslangul E, Saillour M, Dingulu G, Chasset F, Nocturne G, Mariette X, Bitoun S, Seror R. Robert M, et al. Among authors: bader meunier b. RMD Open. 2025 Jun 4;11(2):e005191. doi: 10.1136/rmdopen-2024-005191. RMD Open. 2025. PMID: 40473271 Free PMC article.
Predictive factors of comorbid attention-deficit/hyperactivity disorder in early systemic autoimmune and auto-inflammatory disorders.
Daniel B, Acquaviva E, Bader-Meunier B, Belot A, Dingulu G, Dumaine C, Faye A, Frémond ML, Lavialle L, Meinzer U, Quartier P, Vinit C, Delorme R, Melki I, Ellul P. Daniel B, et al. Among authors: bader meunier b. Pediatr Rheumatol Online J. 2025 Jun 2;23(1):62. doi: 10.1186/s12969-025-01103-5. Pediatr Rheumatol Online J. 2025. PMID: 40457420 Free PMC article.
Myositis specific autoantibody subtypes are associated with response to Janus kinase inhibitors in patients with juvenile dermatomyositis.
Bader-Meunier B, Moreau TRJ, Aeschlimann FA, Authier FJ, Charuel JL, Jouen F, Boyer O, Bodemer C, Welfringer-Morin A, Bondet V, Fournier B, Quartier P, Frémond ML, Foray AP, Sanchez C, Duffy D, Gitiaux C, Rodero MP. Bader-Meunier B, et al. Rheumatology (Oxford). 2025 May 24:keaf214. doi: 10.1093/rheumatology/keaf214. Online ahead of print. Rheumatology (Oxford). 2025. PMID: 40411753
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activity.
Bouazza N, Semeraro M, Lui G, Froelicher-Bournaud L, Choupeaux L, Treluyer JM, Benaboud S, Terzic J, Hachulla E, Remy P, Harambat J, Karras A, Rousset-Rouviere C, Jolivot A, Amoura Z, Daugas E, Hummel A, Salomon R, Lega JC, Decramer S, Belot A, Gobert D, Costedoat-Chalumeau N, Faguer S, Melki I, Jourde-Chiche N, Bader-Meunier B. Bouazza N, et al. Among authors: bader meunier b. Br J Clin Pharmacol. 2025 May 23. doi: 10.1002/bcp.70103. Online ahead of print. Br J Clin Pharmacol. 2025. PMID: 40411119
Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force.
Ravelli A, Rosina S, MacMahon JM, Baird T, Rebollo-Giménez AI, Hinze C, McCann LJ, Reed AM, Rider LG, Arvigo M, Bader-Meunier B, Bruno C, Caifeng L, Campanilho-Marques R, Cuccato S, Fiorillo C, Hahn NA, Huber AM, Jansen M, Kasapcopur O, Katsikas MM, Kim S, Livermore P, Maillard S, Malattia C, Migowa AN, Miyamae T, Murphy R, Nicolai R, Papadopoulou C, Pilkington C, Sanner H, Sawhney S, Smolewska E, Tarvin SE, Tiller G, Toplak N, Wedderburn LR, Bovis F, Consolaro A, Feldman BM. Ravelli A, et al. Among authors: bader meunier b. Ann Rheum Dis. 2025 Jul;84(7):1055-1067. doi: 10.1016/j.ard.2025.04.024. Epub 2025 May 22. Ann Rheum Dis. 2025. PMID: 40410052
Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacy.
Veldkamp SR, Reugebrink M, Evers SW, Moreau TRJ, Bondet V, Armbrust W, van den Berg JM, Hissink Muller PCE, Kamphuis S, Schatorjé E, Delemarre EM, van der Kooi AJ, Bader-Meunier B, Duffy D, Rodero MP, Raaphorst J, van Royen-Kerkhof A, Jansen MHA, van Wijk F. Veldkamp SR, et al. Among authors: bader meunier b. Rheumatology (Oxford). 2025 May 15:keaf227. doi: 10.1093/rheumatology/keaf227. Online ahead of print. Rheumatology (Oxford). 2025. PMID: 40372702
Indications, efficacy, safety of rituximab in childhood-onset systemic lupus erythematosus: a retrospective study of the JIR cohort.
Cognard J, Pietrement C, Laurent A, Fouillet-Desjonquères M, Moran-Alvarez P, Reumaux H, Leguevaques D, Hatchuel Y, Felix A, Pillet P, Rebelle C, Urbina D, Quartier-Dit-Maire P, Melki I, Aeschlimann FA, Koné-Paut I, Rossi-Semerano L, Pha M, Hofer M, Plassart S, Bader-Meunier B, Belot A. Cognard J, et al. Among authors: bader meunier b. Rheumatology (Oxford). 2025 Apr 25:keaf231. doi: 10.1093/rheumatology/keaf231. Online ahead of print. Rheumatology (Oxford). 2025. PMID: 40279484
301 results